avi-4020
Nucleic acidexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2004 (NCT00091845)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- West Nile virusANTISENSE INHIBITOR
West Nile virus antisense inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- avi-4020
- avi-4020
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00387283 | Phase 1 | Oct 1, 2006 | NW Kinetics, Sarepta Therapeutics |
| NCT00091845 | Phase 1 | Nov 1, 2004 | Sarepta Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sarepta Therapeutics | For profit | 2 | 2 | 1 | 2004 |
| NW Kinetics | For profit | 1 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1